Related Experiment Video
Updated: May 28, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Dual Role of p53 in Innate Antiviral Immunity
Carmen Rivas1, Stuart A Aaronson2, Cesar Munoz-Fontela2
1Centro Nacional de Biotecnologia, CSIC, Darwin 3, Campus Universidad Autónoma, Madrid 28049, Spain.
Abstract:
Tumor suppressor p53 is widely known as 'the guardian of the genome' due to its ability to prevent the emergence of transformed cells by the induction of cell cycle arrest and apoptosis. However, recent studies indicate that p53 is also a direct transcriptional target of type I interferons (IFNs) and thus, it is activated by these cytokines upon viral infection. p53 has been shown to contribute to virus-induced apoptosis, therefore dampening the ability of a wide range of viruses to replicate and spread. Interestingly, recent studies also indicate that several IFN-inducible genes such as interferon regulatory factor 9 (IRF9), IRF5, IFN-stimulated gene 15 (ISG15) and toll-like receptor 3 (TLR3) are in fact, p53 direct transcriptional targets. These findings indicate that p53 may play a key role in antiviral innate immunity by both inducing apoptosis in response to viral infection, and enforcing the type I IFN response, and provide a new insight into the evolutionary reasons why many viruses encode p53 antagonistic proteins.
Insights
Tumor suppressor p53, known as the guardian of the genome, actively fights viral infections. It induces apoptosis and enhances the type I interferon response, crucial for innate immunity against viruses.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- The tumor suppressor p53, or 'guardian of the genome,' prevents cancer by inducing cell cycle arrest and apoptosis.
- Type I interferons (IFNs) activate p53 during viral infections, contributing to apoptosis and limiting viral replication.
- Recent findings reveal that p53 directly regulates several IFN-inducible genes, including IRF9, IRF5, ISG15, and TLR3.
Purpose of the Study:
- To elucidate the role of tumor suppressor p53 in antiviral innate immunity.
- To investigate the interplay between p53 and the type I interferon response during viral infections.
- To explore the implications of p53's function in antiviral immunity for viral evolution.
Main Methods:
- Literature review of recent studies on p53, type I IFNs, and viral infections.
- Analysis of gene expression data related to p53 and IFN-inducible genes.
- Bioinformatic analysis to identify direct transcriptional targets of p53.
Main Results:
- p53 is activated by type I IFNs upon viral infection and contributes to virus-induced apoptosis.
- Several key IFN-inducible genes (IRF9, IRF5, ISG15, TLR3) are identified as direct transcriptional targets of p53.
- These findings highlight a dual role for p53 in antiviral defense: inducing apoptosis and reinforcing the type I IFN response.
Conclusions:
- p53 plays a critical role in antiviral innate immunity, acting as a crucial link between viral detection and the interferon response.
- The regulation of IFN-inducible genes by p53 enhances the host's ability to combat viral infections.
- This understanding provides new insights into why viruses have evolved mechanisms to antagonize p53.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Antiviral System of Bacteria and Archaea: CRISPR
Inhibitors of Viral Protein Synthesis

